TGFB1 and pemphigus foliaceus: TGF-β1 receptor inhibitor GW788388 effectively inhibited TGF-β1-induced EMT in HPMCs, as well as improved PF and peritoneal membrane function in a PF mouse model (Lho et al., 2021).